Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Tali7
    Junior Member
    • Aug 2011
    • 8

    Help with smallRNA Truseq kit - Agilent results? (repost from Illumina forum)

    Hi guys! I'm a newbie to this forum so please bear with me! I did ask in the Illumina forum yesterday but didn't get any replies, so I thought I'd ask the RNA experts..

    I've prepared lots of Illumina libraries before (RADseq, RNAseq..) and am now doing miRNAseq using the TruSeq smallRNA kit, using total RNA input.

    I've got to the pre-gel purification stage (post-PCR) and have run an aliquot on the Agilent Bioanalyser as encouraged to do by the protocol. However, the on-site Bioanalyser isn't new enough to use the suggested High Sensitivity DNA chips, and I had to use a normal DNA chip. So basically I didn't really know what I was looking for in my results graphs.

    I do know that I am supposed to see a peak at ~145-160bp (the adapter-ligated miRNA size). And I do have small peaks in roughly that size region.

    HOWEVER, I also have maaaassive peaks at ~270bp. I have no idea what this could be, and nobody I've spoken to knows either! I know it isn't contamination, because a sample that is effectively my -ve control (don't ask) didn't have any peaks. I'm just concerned that, as the peaks are so big, the adapters (although designed to ligate to miRNA) have also ligated to bigger RNA too, and so have also been amplified in PCR.

    Would this be possible, and/or does anybody have any idea what these 270bp peaks are doing in my library prep?!

    Thanks so much
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    This is after PCR "enrichment"? If so, that is the multimeric or hetero-strand dimer product common in TruSeq libraries. It is called, variously, "bird nesting", "daisy chaining", "bubble products", etc. For my formulation of various possibilities, see:

    Bridged amplification & clustering followed by sequencing by synthesis. (Genome Analyzer / HiSeq / MiSeq)


    The good news is that it usually is not a problem because most of the time the extra peak disappears after strand denaturation. You could try running a pico RNA chip on the DNA after denaturation. See:

    Bridged amplification & clustering followed by sequencing by synthesis. (Genome Analyzer / HiSeq / MiSeq)


    But, should the sample strands re-anneal, you may get confusing results due to single stranded molecules running slower on Agilent chips than double stranded ones:

    Techniques and protocol discussions on sample preparation, library generation, methods and ideas

    Techniques and protocol discussions on sample preparation, library generation, methods and ideas


    --
    Phillip

    Comment

    • Tali7
      Junior Member
      • Aug 2011
      • 8

      #3
      Hi Phillip

      Wow I hadn't realised that this was such a well-known problem! I hadn't checked the other forums as I assumed it was a problem restricted to miRNAseq, rather than a general Truseq issue. It definitely looks like it could be dimer product - it is roughly twice the size of the desired product (~270bp cf. 145-160bp).

      Thanks very much

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      32 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Working...